Boers M, Buttgereit F, Saag K, Alten R, Grahn A, Storey D, Rice P, Kirwan J
VU University Medical Center, Amsterdam, The Netherlands.
Charité University Medicine, Berlin, Germany.
Arthritis Care Res (Hoboken). 2015 Sep;67(9):1202-1209. doi: 10.1002/acr.22592.
Little is known about the relationship between morning symptoms of rheumatoid arthritis (RA) and measures of disease activity currently used to assess RA. Information available from the Circadian Administration of Prednisone in Rheumatoid Arthritis (CAPRA-2) study was used to investigate these relationships.
CAPRA-2 included 350 patients with RA who were symptomatic despite treatment with disease-modifying antirheumatic drugs, randomized 2:1 to additional treatment with a 5-mg daily dose of delayed-release prednisone or placebo. Pearson's correlations were used to evaluate the relationships between change from baseline in symptoms (duration of morning stiffness, severity of morning stiffness, and intensity of pain on waking) and measures of disease activity (the American College of Rheumatology 20% improvement criteria [ACR20], the Disease Activity Score in 28 joints [DAS28], and the Health Assessment Questionnaire disability index). Correlations were defined as weak (<0.3), moderate (0.3-0.7), or strong (>0.7).
There was a strong correlation between the severity of morning stiffness and the intensity of morning pain (Pearson's correlation 0.91, P < 0.001). There was a weak correlation between the duration of morning stiffness and measures of disease activity (0.24-0.28), with moderate correlations between the severity of morning stiffness or intensity of pain on waking and DAS28 or ACR20 scores (0.44-0.48). Severity of morning stiffness showed less variability and a greater effect size than did duration of morning stiffness.
Morning symptoms and measures of disease activity show weak to moderate correlations. Severity of morning stiffness showed less variability and greater effect size than did duration of morning stiffness. These findings suggest that severity is the preferred construct to measure the impact of morning stiffness in patients with RA, information that is not fully captured in the RA core set.
类风湿关节炎(RA)的晨僵症状与目前用于评估RA疾病活动度的指标之间的关系鲜为人知。利用类风湿关节炎中泼尼松的昼夜给药(CAPRA - 2)研究中获得的信息来调查这些关系。
CAPRA - 2纳入了350例尽管接受了改善病情抗风湿药物治疗仍有症状的RA患者,按2:1随机分为两组,分别接受每日5毫克缓释泼尼松或安慰剂的额外治疗。采用Pearson相关性分析来评估症状(晨僵持续时间、晨僵严重程度和醒来时疼痛强度)相对于基线的变化与疾病活动度指标(美国风湿病学会20%改善标准[ACR20]、28个关节的疾病活动评分[DAS28]和健康评估问卷残疾指数)之间的关系。相关性被定义为弱(<0.3)、中度(0.3 - 0.7)或强(>0.7)。
晨僵严重程度与晨痛强度之间存在强相关性(Pearson相关性为0.91,P < 0.001)。晨僵持续时间与疾病活动度指标之间存在弱相关性(0.24 - 0.28),晨僵严重程度或醒来时疼痛强度与DAS28或ACR20评分之间存在中度相关性(0.44 - 0.48)。与晨僵持续时间相比,晨僵严重程度的变异性较小且效应量更大。
晨僵症状与疾病活动度指标之间显示出弱至中度相关性。与晨僵持续时间相比,晨僵严重程度的变异性较小且效应量更大。这些发现表明,严重程度是衡量RA患者晨僵影响的首选指标,而这一信息在RA核心指标集中并未完全体现。